A Q&A with W. Kimryn Rathmell as she takes the reins at NCI
Product Development
Product Development
Spotlight on early-stage solid tumor trials with emerging innate immune targets: ALPK1 and ENPP1
Finance
Plus rounds for Rubedo, Flindr, Endeavor, SynOx and more
Management Tracks
Plus: Meenu Chhabra Karson becomes chair at Harness, and an update from Ontada
BioCentury ISSN 1097-7201